References
- Sahoo T, Cheung SW, Ward P, et al. Prenatal diagnosis of chromosomal abnormalities using array-based comparative genomic hybridization. Genet Med 2006;8:719–27
- Van den Veyver IB, Patel A, Shaw CA, et al. Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn 2009;29:29–39
- Shaffer LG, Dabell MP, Rosenfeld JA, et al. Referral patterns for microarray testing in prenatal diagnosis. Prenat Diagn 2012;32:344–50
- Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367:2175–84
- Nagamani SC, Erez A, Bay C, et al. Delineation of a deletion region critical for corpus callosal abnormalities in chromosome 1q43-q44. Eur J Hum Genet 2012;20:176–9
- Rowe AG, Abrams L, Qu Y, et al. Tetrasomy 15q25–>qter: cytogenetic and molecular characterization of an analphoid supernumerary marker chromosome. Am J Med Genet 2000;93:393–8
- Chen CP, Lin CC, Li YC, et al. Clinical, cytogenetic, and molecular analyses of prenatally diagnosed mosaic tetrasomy for distal chromosome 15q and review of the literature. Prenat Diagn 2004;24:767–73
- Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749–64
- ACOG committee opinion no. 446. Array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol 2009;114:1161–3
- Lewis C, Skirton H, Jones R. Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing?. J Genet Couns 2011;20:80–97
- Bernhardt BA, Soucier D, Hanson K, et al. Women’s experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med 2013;15:139–45
- Donley G, Hull SC, Berkman BE. Prenatal whole genome sequencing: just because we can, should we?. Hastings Cent Rep 2012;42:28–40
- Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 2011;13:499–504
- McGillivray G, Rosenfeld JA, McKinlay Gardner RJ, Gillam LH. Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing. Prenat Diagn 2012;32:389–95
- Benacerraf BR. The history of the second-trimester sonographic markers for detecting fetal down syndrome, and their current role in obstetric practice. Prenat Diagn 2010;30:644–52
- Elias S, Annas GJ. Generic consent for genetic screening. N Engl J Med 1994;330:1611–13
- Ormond KE, Iris M, Banuvar S, et al. What do patients prefer: Informed consent models for genetic carrier testing. J Genet Couns 2007;16:539–50
- Girirajan S, Rosenfeld JA, Coe BP, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012;367:1321–31
- Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012;4:1--13
- Reiff M, Ross K, Mulchandani S, et al. Physicians’ perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clin Genet 2013;83:23–30